Longevity Biotech Sector Gains Traction as 27 Trillion Healthcare Shift Targets Cell Restoration Therapies RY Q1 2026 Earnings Modest EPS Beat as Shares Edge Lower Space Stocks Slide as Blue Origin Rocket Explosion and SpaceX Valuation Concerns Weigh on Sector